NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EarliPoint Health

EarliPoint Health

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://earlipointhealth.com/

Last Round

Series B

Apr 2, 2024

Total Funding Raised

$41M

Company Overview

EarliPoint Health is a healthcare technology company that develops and commercializes an FDA-cleared device to aid in the early diagnosis and assessment of Autism Spectrum Disorder (ASD) in children.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

autism diagnosisASD diagnosiseye-tracking technologyearly autism diagnosismedical deviceAI diagnosticsdigital biomarkerautism biomarkerautism techFDA-cleared deviceclinical decision supportmedical AIcomputer visionpediatric diagnosticsprovider networkexplainable AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EarliPoint Health Comps

Public and private peers based on sector, stage, and business model.

EarliPoint Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EarliPoint Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 2, 2024
Series AFeb 18, 2022

EarliPoint Health Investors

Notable investors and investment history

EarliPoint Health investors
InvestorRounds
Clarevia VenturesSeries B
Nexus NeuroTech VenturesSeries B
Georgia Research AllianceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2024

    $22M round led by Clarevia Ventures and Nexus NeuroTech Ventures.

  • Feb 18, 2022

    $20M round led by Bernard Marcus

EarliPoint Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EarliPoint Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EarliPoint Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Year Founded2019
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.